News & Updates
Filter by Specialty:
Telitacicept shows promise in systemic lupus erythematosus
Telitacicept, a novel fusion protein that neutralizes signals of B lymphocyte stimulator and a proliferation-inducing ligand, is safe and helps improve the symptoms of systemic lupus erythematosus, as shown in a phase IIb study.
Telitacicept shows promise in systemic lupus erythematosus
30 Dec 2023
Low-dose naltrexone in fibromyalgia: No pain relief, but memory boost possible
In the treatment of individuals with fibromyalgia, low-dose naltrexone does not appear to help reduce pain but might improve memory instead, as reported in a study.
Low-dose naltrexone in fibromyalgia: No pain relief, but memory boost possible
22 Dec 2023
Auricular vagus nerve stimulation of little benefit in rheumatoid arthritis
Auricular vagus nerve stimulation (VNS) does not appear to be efficacious at managing disease activity in individuals with rheumatoid arthritis, as reported in a study.
Auricular vagus nerve stimulation of little benefit in rheumatoid arthritis
19 Dec 2023
Obesity persists in axSpA, especially in socially deprived patients
Obesity appears to be prevalent among patients with axial spondyloarthritis (axSpA) compared to the general population, according to a Swiss study, noting that socially disadvantaged individuals are most affected by this comorbidity.
Obesity persists in axSpA, especially in socially deprived patients
11 Dec 2023
JAK inhibitors shown safe, effective in RA patients
A recent study has demonstrated the safety and efficacy of oral Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis (RA) in the real-world setting, particularly in those who do not present with cardiovascular risk factors at baseline.